Treatment effect of ginsenoside CK on acute myocardial infarction

A technology of ginsenoside and acute myocardial infarction, which is applied in the field of medicine and can solve problems such as increasing myocardial contractility

Inactive Publication Date: 2017-06-13
SHANGHAI UNIV OF T C M
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although, 200510078482.3 (CN1879640A) discloses the use of ginsenoside Rh2, Ck and Rg3 in increasing myocardial contractility, but there is no literature report that ginsenoside CK can be u

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment effect of ginsenoside CK on acute myocardial infarction
  • Treatment effect of ginsenoside CK on acute myocardial infarction
  • Treatment effect of ginsenoside CK on acute myocardial infarction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] 1. Experimental materials

[0027] 1.1 Medicinal materials

[0028] Ginsenoside CK (molecular weight 622.44, HPLC purity ≥ 99%, Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine); Notoginsenoside Fe, Notoginsenoside R1 (HPLC purity ≥ 99%, Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine)), Danshen injection Liquid (purchased from Shanghai Green Valley Pharmaceutical Co., Ltd., batch number: 1505031);

[0029] 1.2 Experimental animals

[0030] SD rats weighing 220±20 g were provided by the Experimental Animal Center of Shanghai University of Traditional Chinese Medicine, animal certificate number: SYXK (Shanghai) 2008-0016. Placed in a conventional feeding environment, free access to food and water.

[0031] 2. Method:

[0032] Model making method: SD rats (provided by Animal Experiment Center of Shanghai University of Traditional Chinese Medicine), body weight: 220-270g. Rats...

Embodiment 2

[0050] A pharmaceutical preparation of ginsenoside CK, which is a medicament made from the following raw materials in weight ratio:

[0051]

[0052]

[0053] Get ginsenoside CK and dissolve in a small amount of water; microcrystalline cellulose, mannitol, and sodium carboxymethyl starch are passed through a 100-mesh sieve and mixed evenly, add ginsenoside CK solution and fully stir, 2% hydroxyethyl methylcellulose solution is Soft material made of binder, pass through 80-mesh sieve to make granules, wet granules are air-dried in oven at 40°C; dry granules are granulated through 80-mesh sieve, mixed with calcium stearate, and filled into capsules.

Embodiment 3

[0055] A pharmaceutical preparation of ginsenoside CK, which is a medicament made from the following raw materials in weight ratio:

[0056]

[0057] Get ginsenoside CK and dissolve in a small amount of water; microcrystalline cellulose, mannitol, and sodium carboxymethyl starch are passed through a 100-mesh sieve and mixed evenly, add ginsenoside CK solution and fully stir, 2% hydroxyethyl methylcellulose solution is Binder made of soft material, pass through 80-mesh sieve to make granules, wet granules are air-dried in oven at 40°C; dry granules are granulated through 80-mesh sieve, and compressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicine, in particular to a medical use of ginsenoside CK. The ginsenoside CK can be used for preventing acute myocardial infarction.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a use of ginsenoside CK for treating acute myocardial infarction. Background technique [0002] Acute myocardial infarction (AMI) refers to the acute necrosis of part of the myocardium caused by persistent and severe myocardial ischemia. Acute myocardial infarction refers to the acute occlusion of the coronary artery, interruption of blood flow, resulting in ischemic necrosis of the local myocardium. Acute myocardial infarction is a severe type of coronary heart disease. The basic cause is coronary atherosclerosis, resulting in severe stenosis of the lumen and insufficient blood supply to the myocardium, while the collateral circulation is not fully established. On this basis, once the blood supply is further sharply reduced or interrupted, resulting in severe and persistent acute ischemia of the myocardium for more than 1 hour, myocardial infarction can occur. Clinically, it often mani...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7032A61P9/10
CPCA61K9/0019A61K9/08A61K9/19A61K9/2059A61K31/7032
Inventor 王峥涛高波鞠政财张二云李佳杨莉吴晓俊
Owner SHANGHAI UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap